NF2 and neoplasm: The most common alterations were BAP1 mutations (n = 5; of note, BAP1 was assessed only by the 14MG panel and only in the tumour specimen, no germline analysis), CDKN2A loss (n = 2) and NF2 mutation (n = 2; to note, NF2 was assessed only by the 14MG panel) (Fig. 3c).